Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Ionizing Radiation | Review

The immunomodulatory properties of low-level ionizing radiation as a potential treatment for COVID-19’s life-threatening symptoms

Author: Soha M. Hussien

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Public health experts are looking into the current coronavirus outbreak to see if there are any ways to prevent potentially fatal symptoms. Low-Dose Radiotherapy (LD-RT) induces anti-inflammatory cytokine responses that act as a counterweight to pro-inflammatory cytokines, potentially providing therapeutic benefits for COVID-19-related diseases associated with significant morbidity and mortality. This study will look into positive immuno-radiological reactions to see if they are feasible, practicable, and effective in lowering the critical inflammatory condition of the crucial stage COVID-19. This study aims to investigate the use of low-dose lung radiation in bacterial and viral pneumonia, as well as to provide a treatment plan for COVID-19-associated pneumonia. This article discusses the evidence for and against LD-RT theories in COVID-19 patients. The use of LD-RT at various stages of COVID-19 appears to be beneficial, with fewer side effects than other currently being studied treatments.
Literature
1.
Poon LLM, Guan Y, Nicholls JM, Yuen KY, Peiris JSM. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis. 2004;4:663–71.CrossRefPubMedPubMedCentral
2.
3.
Dhawan G, Kapoor R, Dhawan R, Singh R, Monga B, Giordano J, Calabrese EJ. Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol. 2020;147:212–6.CrossRefPubMedPubMedCentral
4.
5.
Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiother Oncol. 2020;147:217–20.CrossRefPubMedPubMedCentral
6.
Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013;86:555.PubMedPubMedCentral
7.
8.
Schaue D, Jahns J, Hildebrandt G, Trott K-R. Radiation treatment of acute inflammation in mice. Int J Radiat Biol. 2005;81:657–67.CrossRefPubMed
9.
Rödel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007;83:357–66.CrossRefPubMed
10.
Torres Royo L, Antelo Redondo G, Árquez Pianetta M, Arenas Prat M. Low-dose radiation therapy for benign pathologies. Reports Pract Oncol Radiother. 2020;25:250–4.CrossRef
11.
Oppenheimer A. Roentgen therapy of “virus” pneumonia. Am J Roentgenol Radiat Ther. 1943;49:635–8.
12.
Correll HL, Cowan II. Primary atypical pneumonia, analysis of therapeutic results in 155 cases. US Nav M Bull. 1943;41:980–7.
13.
Trott KR. Therapeutic effects of low radiation doses. Strahlentherapie und Onkol Organ der Dtsch Rontgengesellschaft [et al]. 1994;170:1–12.
14.
Fried C. The roentgen treatment of experimental pneumonia in the guinea-pig. Radiology. 1941;37(2):197–202.CrossRef
15.
Lieberman LM, Hodes PJ, Leopold SS. Roentgen therapy of experimental lobar pneumonia in dogs. Am. J. Med. Sci. 1941;291(1):92–100.CrossRef
16.
Dubin IN, Baylin GJ, Gobble Jr WG. The effect of roentgen therapy on experimental virus pneumonia; on pneumonia produced in white mice by swine influenza virus. Am J Roentgenol Radium Ther. 1946;55:478–81.PubMed
17.
Salomaa S, Cardis E, Bouffler SD, Atkinson MJ, Hamada N. Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence? Int J Radiat Biol. 2020;96:1224–7.CrossRefPubMed
18.
19.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.CrossRefPubMedPubMedCentral
20.
21.
Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762–8.CrossRefPubMed
22.
23.
24.
Nakatsukasa H, Tsukimoto M, Ohshima Y, Tago F, Masada A, Kojima S. Suppressing effect of low-dose gamma-ray irradiation on collagen-induced arthritis. J Radiat Res. 2008;49:381–9.CrossRefPubMed
25.
Nakatsukasa H, Tsukimoto M, Tokunaga A, Kojima S. Repeated gamma irradiation attenuates collagen-induced arthritis via up-regulation of regulatory T cells but not by damaging lymphocytes directly. Radiat Res. 2010;174:313–24.CrossRefPubMed
26.
Weng L, Williams RO, Vieira PL, Screaton G, Feldmann M, Dazzi F. The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activity. Ann Rheum Dis. 2010;69:1519–26.CrossRefPubMed
27.
Calabrese EJ, Calabrese V. Reduction of arthritic symptoms by low dose radiation therapy (LD-RT) is associated with an anti-inflammatory phenotype. Int J Radiat Biol. 2013;89:278–86.CrossRefPubMed
28.
Seegenschmiedt MH, Micke O, Muecke R. Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol. 2015;88:20150080.CrossRefPubMedPubMedCentral
29.
30.
31.
Kriz J, Seegenschmiedt HM, Bartels A, Micke O, Muecke R, Schaefer U, Haverkamp U, Eich HT. Updated strategies in the treatment of benign diseases—a patterns of care study of the german cooperative group on benign diseases. Adv Radiat Oncol. 2018;3:240–4.CrossRefPubMedPubMedCentral
32.
Seegenschmiedt MH, Katalinic A, Makoski H-B, Haase W, Gademann G, Hassenstein E. Radiation therapy for benign diseases: patterns of care study in Germany. Int J Radiat Oncol Biol Phys. 2000;47:195–202.CrossRefPubMed
33.
Micke O, Seegenschmiedt MH. Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys. 2002;52:496–513.CrossRefPubMed
34.
35.
Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose. Hum Exp Toxicol. 2019;38:888–98.CrossRefPubMed
36.
Arenas M, Sabater S, Hernández V, Rovirosa A, Lara PC, Biete A, Panes J. Anti-inflammatory effects of low-dose radiotherapy. Strahlenther Onkol. 2012;188:975–81.CrossRefPubMed
37.
38.
McKeown SR, Hatfield P, Prestwich RJD, Shaffer RE, Taylor RE. Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Br J Radiol. 2015;88:20150405.CrossRefPubMedPubMedCentral
39.
Genard G, Lucas S, Michiels C. Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies. Front Immunol. 2017;8:828.CrossRefPubMedPubMedCentral
40.
Klug F, Prakash H, Huber PE, et al. Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell. 2013;24:589–602.CrossRefPubMed
41.
Rödel F, Frey B, Manda K, Hildebrandt G, Hehlgans S, Keilholz L, Seegenschmiedt MH, Gaipl US, Rödel C. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation. Front Oncol. 2012;2:120.CrossRefPubMedPubMedCentral
42.
Ghadimi-Moghadam A, Haghani M, Bevelacqua JJ, Jafarzadeh A, Kaveh-Ahangar A, Mortazavi SMJ, Ghadimi-Moghadam A, Mortazavi SAR. COVID-19 tragic pandemic: concerns over unintentional “directed accelerated evolution” of novel coronavirus (SARS-CoV-2) and introducing a modified treatment method for ARDS. J Biomed Phys Eng. 2020;10:241.
43.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.CrossRefPubMedPubMedCentral
44.
Yang G, Kong Q, Wang G, Jin H, Zhou L, Yu D, Niu C, Han W, Li W, Cui J. Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy. Cancer Biother Radiopharm. 2014;29:428–34.PubMedPubMedCentral
45.
Thevarajan I, Nguyen THO, Koutsakos M, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26:453–5.CrossRefPubMedPubMedCentral
46.
47.
Yazdany J, Kim AHJ. Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know. Ann Intern Med. 2020;172:754–5.CrossRefPubMed
48.
Trott K-R, Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlentherapie und Onkol. 2006;182:431–6.CrossRef
49.
Nikitaki Z, Nikolov V, Mavragani IV, et al. Measurement of complex DNA damage induction and repair in human cellular systems after exposure to ionizing radiations of varying linear energy transfer (LET). Free Radic Res. 2016;50:S64–78.CrossRefPubMed
50.
Georgakilas AG, O’Neill P, Stewart RD. Induction and repair of clustered DNA lesions: what do we know so far? Radiat Res. 2013;180:100–9.CrossRefPubMed
51.
52.
Metadata
Title
The immunomodulatory properties of low-level ionizing radiation as a potential treatment for COVID-19’s life-threatening symptoms
Author
Soha M. Hussien
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-00999-7

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device

Research

Amoxicillin-induced aseptic meningitis: clinical features, diagnosis and management

Research

The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity

Research

Bibliometric and visual analysis of diabetes mellitus and pyroptosis from 2011 to 2022

Research

Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia–reperfusion acute kidney injury and post-injury fibrosis

Research

Remimazolam tosylate's long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety